144 related articles for article (PubMed ID: 34231919)
1. Magnetic Resonance Imaging Correlates of Multiple Sclerosis Immunopathological Patterns.
Metz I; Gavrilova RH; Weigand SD; Frischer JM; Popescu BF; Guo Y; Gloth M; Tobin WO; Zalewski NL; Lassmann H; Tillema JM; Erickson BJ; Parisi JE; Becker S; König FB; Brück W; Lucchinetti CF
Ann Neurol; 2021 Sep; 90(3):440-454. PubMed ID: 34231919
[TBL] [Abstract][Full Text] [Related]
2. Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.
Stork L; Ellenberger D; Beißbarth T; Friede T; Lucchinetti CF; Brück W; Metz I
JAMA Neurol; 2018 Apr; 75(4):428-435. PubMed ID: 29404583
[TBL] [Abstract][Full Text] [Related]
3. Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.
Absinta M; Sati P; Masuzzo F; Nair G; Sethi V; Kolb H; Ohayon J; Wu T; Cortese ICM; Reich DS
JAMA Neurol; 2019 Dec; 76(12):1474-1483. PubMed ID: 31403674
[TBL] [Abstract][Full Text] [Related]
4. Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.
Absinta M; Sati P; Schindler M; Leibovitch EC; Ohayon J; Wu T; Meani A; Filippi M; Jacobson S; Cortese IC; Reich DS
J Clin Invest; 2016 Jul; 126(7):2597-609. PubMed ID: 27270171
[TBL] [Abstract][Full Text] [Related]
5. Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process.
Absinta M; Sati P; Gaitán MI; Maggi P; Cortese IC; Filippi M; Reich DS
Ann Neurol; 2013 Nov; 74(5):669-78. PubMed ID: 23813441
[TBL] [Abstract][Full Text] [Related]
6. Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.
Harrison DM; Li X; Liu H; Jones CK; Caffo B; Calabresi PA; van Zijl P
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1447-53. PubMed ID: 26939635
[TBL] [Abstract][Full Text] [Related]
7. Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.
Dal-Bianco A; Grabner G; Kronnerwetter C; Weber M; Höftberger R; Berger T; Auff E; Leutmezer F; Trattnig S; Lassmann H; Bagnato F; Hametner S
Acta Neuropathol; 2017 Jan; 133(1):25-42. PubMed ID: 27796537
[TBL] [Abstract][Full Text] [Related]
8. Iron Heterogeneity in Early Active Multiple Sclerosis Lesions.
Tham M; Frischer JM; Weigand SD; Fitz-Gibbon PD; Webb SM; Guo Y; Adiele RC; Robinson CA; Brück W; Lassmann H; Furber KL; Pushie MJ; Parisi JE; Lucchinetti CF; Popescu BF
Ann Neurol; 2021 Mar; 89(3):498-510. PubMed ID: 33244761
[TBL] [Abstract][Full Text] [Related]
9. Automated separation of diffusely abnormal white matter from focal white matter lesions on MRI in multiple sclerosis.
Maranzano J; Dadar M; Zhernovaia M; Arnold DL; Collins DL; Narayanan S
Neuroimage; 2020 Jun; 213():116690. PubMed ID: 32119987
[TBL] [Abstract][Full Text] [Related]
10. Antibody signatures in patients with histopathologically defined multiple sclerosis patterns.
Stork L; Ellenberger D; Ruprecht K; Reindl M; Beißbarth T; Friede T; Kümpfel T; Gerdes LA; Gloth M; Liman T; Paul F; Brück W; Metz I
Acta Neuropathol; 2020 Mar; 139(3):547-564. PubMed ID: 31950335
[TBL] [Abstract][Full Text] [Related]
11. Pathologic heterogeneity persists in early active multiple sclerosis lesions.
Metz I; Weigand SD; Popescu BF; Frischer JM; Parisi JE; Guo Y; Lassmann H; Brück W; Lucchinetti CF
Ann Neurol; 2014 May; 75(5):728-38. PubMed ID: 24771535
[TBL] [Abstract][Full Text] [Related]
12. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
Miller DH; Grossman RI; Reingold SC; McFarland HF
Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
[TBL] [Abstract][Full Text] [Related]
13. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
Kilsdonk ID; Jonkman LE; Klaver R; van Veluw SJ; Zwanenburg JJ; Kuijer JP; Pouwels PJ; Twisk JW; Wattjes MP; Luijten PR; Barkhof F; Geurts JJ
Brain; 2016 May; 139(Pt 5):1472-81. PubMed ID: 26956422
[TBL] [Abstract][Full Text] [Related]
14. Diffusivity in multiple sclerosis lesions: At the cutting edge?
Klistorner A; Wang C; Fofanova V; Barnett MH; Yiannikas C; Parratt J; You Y; Graham SL
Neuroimage Clin; 2016; 12():219-26. PubMed ID: 27489769
[TBL] [Abstract][Full Text] [Related]
15. Paramagnetic Rim Lesions in Multiple Sclerosis: Comparison of Visualization at 1.5-T and 3-T MRI.
Hemond CC; Reich DS; Dundamadappa SK
AJR Am J Roentgenol; 2022 Jul; 219(1):120-131. PubMed ID: 34851712
[No Abstract] [Full Text] [Related]
16. Degree of microstructural changes within T1-SE versus T1-GE hypointense lesions in multiple sclerosis: relevance for the definition of "black holes".
Lapucci C; Romano N; Schiavi S; Saitta L; Uccelli A; Boffa G; Pardini M; Signori A; Castellan L; Inglese M; Roccatagliata L
Eur Radiol; 2020 Jul; 30(7):3843-3851. PubMed ID: 32162002
[TBL] [Abstract][Full Text] [Related]
17. T2 hypointense rims and ring-enhancing lesions in MS.
Llufriu S; Pujol T; Blanco Y; Hankiewicz K; Squarcia M; Berenguer J; Villoslada P; Graus F; Saiz A
Mult Scler; 2010 Nov; 16(11):1317-25. PubMed ID: 20685762
[TBL] [Abstract][Full Text] [Related]
18. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
19. MRI predictors for the conversion from contrast-enhancing to iron rim multiple sclerosis lesions.
Wenzel N; Wittayer M; Weber CE; Schirmer L; Platten M; Gass A; Eisele P
J Neurol; 2022 Aug; 269(8):4414-4420. PubMed ID: 35332392
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions.
Abou Zeid N; Pirko I; Erickson B; Weigand SD; Thomsen KM; Scheithauer B; Parisi JE; Giannini C; Linbo L; Lucchinetti CF
Neurology; 2012 May; 78(21):1655-62. PubMed ID: 22573639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
